Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylateElias Jabbour, Jörge E. Cortes, Xian Zhou et al.|Leukemia|2006Cited by 387
Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitorsJörge E. Cortes, Dan Jones, Elias Jabbour et al.|Blood|2007Cited by 298
CD4+/CD56+ Hematodermic TumorMarco Herling, Dan Jones|American Journal of Clinical Pathology|2007Cited by 172
Systemic mastocytosis with associated clonal hematological non‐mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in <scp>SM</scp> and <scp>AHNMD</scp> componentsSa A. Wang, Roberto N. Miranda, L. Jeffrey Medeiros et al.|American Journal of Hematology|2012Cited by 87